Apoptosis of conjunctival epithelial cells before and after the application of autologous serum eye drops in severe dry eye disease

• Main Authors: Ivana Rybickova, Viera Vesela, Ivan Fales, Pavlina Skalicka, Katerina Jirsova
• Format: Article
• Language: English
• Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-06-01
• Series: Biomedical Papers
• Subjects: apoptosis; autologous serum; dry eye disease; caspase 3; conjunctival epithelium
• Online Access: https://biomed.papers.upol.cz/artkey/bio-201602-0014_Apoptosis_of_conjunctival_epithelial_cells_before_and_after_the_application_of_autologous_serum_eye_drops_in_se.php

Aims: To assess the impact of autologous serum eye drops on the level of ocular surface apoptosis in patients with bilateral severe dry eye disease. Methods: This prospective study was conducted on 10 patients with severe dry eye due to graft versus host disease (group 1) and 6 patients with severe dry eye due to primary Sjögren's syndrome (group 2). Impression cytology specimens from the bulbar conjunctiva were obtained before and after a three-month treatment with 20% autologous serum eye drops applied a maximum of 12 times a day together with regular therapy with artificial tears. The percentage of apoptotic epithelial cells was evaluated immunochemically using anti-active caspase 3 antibody. Results: In group 1, the mean percentage of apoptotic cells was 3.6% before the treatment. The three-month treatment led to a significant decrease to a mean percentage of 1.8% (P = 0.028). The mean percentage of apoptotic conjunctival cells decreased from 5.4% before the treatment to 3.8% in group 2; however, these results did not reach the level of significance. Conclusion: Three-month autologous serum treatment led to the improvement of ocular surface apoptosis, especially in the group of patients with severe dry eye due to graft versus host disease. This result supports the very positive effect of autologous serum on the ocular surface in patients suffering from severe dry eye.